SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune Group is facing extreme volatility as investors weigh a strongly critical FDA briefing document against potential support from patient advocacy groups and physicians ahead of the upcoming advisory committee meeting. Market sentiment remains fractured, with the community intensely debating whether the company can overcome persistent regulatory hurdles regarding trial design and data integrity or if a third Complete Response Letter is inevitable.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network (ZBCN) is trending as the community debates its long-term potential and recent price volatility, with many investors actively accumulating tokens while staking to prepare for anticipated regulatory developments like the Clarity Act. While some vocal critics characterize the project as a pump-and-dump due to recent price declines, a dedicated core of followers remains bullish, citing consistent product milestones, enterprise partnerships, and the growth of the SuperApp as key drivers for future valuation.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is trending as investors weigh the potential for a strategic turnaround under new CEO Michael Severino against ongoing concerns regarding valuation, short interest, and competitive pressures in the DMD space. The community remains deeply divided, with many debating whether the stock's current price represents a distressed buying opportunity or an ongoing decline.

Roblox Corp. engages in the provision of online gaming services. Its platform consists of Roblox Client, Roblox Studio, and Roblox Cloud. Roblox Client is an application that allows users to explore 3D digital worlds. Roblox Studio is the toolset that allows developers and creators to build, publish, and operate 3D experiences and other content accessed with Roblox Client. Roblox Cloud includes the services and infrastructure that power the human co-experience platforms. The company was founded by Erik Cassel and David B. Baszucki in March 2004 and is headquartered in San Mateo, CA.

Roblox Corporation - Ordinary Shares - Class A

Roblox Corp.

Roblox is trending as shares face significant downward pressure following Q2 earnings, where the company missed bookings expectations and withdrew its full-year guidance. Community sentiment is deeply divided, with many traders debating whether the stock represents a deep-value buying opportunity or if the platform is experiencing a structural lifecycle decline.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund is trending as investors react to extreme volatility driven by escalating geopolitical tensions in the Middle East and reports of disrupted shipping routes. The community is sharply divided, with traders actively debating whether the current price action is a fundamental response to supply scarcity or a manipulated outcome of high-stakes diplomatic posturing and potential cease-fire rumors.

Hyperliquid is a layer one (L1) blockchain best known for perpetual futures and spot trading. Beyond its flagship DEX trading platform, the ecosystem supports borrowing, lending, real world assets (RWAs), and a full-fledged Ethereum Virtual Machine (EVM), making it a leading force in decentralized finance (defi).   Just as electronic trading dramatically improved markets in the 2000s, Hyperliquid offers an opportunity for a massive technical upgrade of the existing financial system through a transparent, efficient, and resilient blockchain. HYPE is the native token of the Hyperliquid blockchain, with a maximum supply of 1 billion.

Hype

HYPE is drawing intense attention due to its unique model where the majority of platform fees are automatically funneled into token buybacks, creating a direct feedback loop between trading volume and price. Community sentiment is deeply divided, with many traders viewing recent volatility as a prime accumulation opportunity for long-term growth while others caution that the current price action reflects speculative hype rather than fundamental value.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain as well as the Onyx Goliath Blockchain. XCN is also used as an ERC-20 token for Staking and Governance.

Onyxcoin

Onyxcoin (XCN) is currently trending as community members debate the long-term potential of the Goliath mainnet launch and its utility for institutional finance. While some investors are actively accumulating and staking in anticipation of future adoption and regulatory clarity, others are vocal about their frustration regarding extended periods of stagnant price action and past marketing hype.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), and Global Services (BGS). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The company was founded by William Edward Boeing on July 15, 1916, and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

Boeing continues to be a focal point for investors as the community debates the strength of its operational turnaround, balancing optimism regarding record backlogs and delivery momentum against ongoing concerns over defense program cost overruns and regulatory certification delays. Traders are actively monitoring management's commentary for signs of sustained free cash flow improvement while expressing frustration over the stock's recent price volatility despite positive order flow.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya Technologies is seeing significant bullish momentum driven by consistent earnings beats, insider share purchases, and a series of upsized asset-backed securitization deals that highlight strong institutional demand. While broader macro factors and short-interest volatility persist, the community is actively debating the stock's significant undervaluation relative to peers and the potential for further analyst upgrades.

Occidental Petroleum Corp. engages in the exploration and production of oil and natural gas. It operates through the following segments: Oil and Gas, Chemical, and Midstream and Marketing. The Oil and Gas segment explores for, develops and produces oil and condensate, natural gas liquids, and natural gas. The Chemical segment manufactures and markets basic chemicals and vinyls. The Midstream and Marketing segment purchases, markets, gathers, processes, transports and stores oil, condensate, natural gas liquids, natural gas, carbon dioxide, and power. The company was founded in 1920 and is headquartered in Houston, TX.

Occidental Petroleum Corp.

Occidental Petroleum is experiencing significant volatility as market participants react to mixed signals regarding Middle East geopolitical stability and potential crude supply disruptions. Investors are closely monitoring the interplay between fluctuating oil prices and the company's aggressive debt reduction strategies, while community sentiment remains split on whether current valuations offer a solid entry point or a risk of further downside.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Optimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant Depression

Optimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant Depression Optimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant Depression PR Newswire VANCOUVER, BC, June 29, 2026 Optimi's 5mg psilocybin capsules are prescribed in...

Optimi Health Launches Standardized Microdose Psilocybin Products for Clinical Research

Optimi Health Launches Standardized Microdose Psilocybin Products for Clinical Research Optimi Health Launches Standardized Microdose Psilocybin Products for Clinical Research PR Newswire VANCOUVER, BC, June 16, 2026 Two naturally derived finished drug products, at 1mg and 2mg, give research...

Optimi Health Completes First Export of Psilocybin to the United Kingdom for Phase 2 Clinical Trial

Optimi Health Completes First Export of Psilocybin to the United Kingdom for Phase 2 Clinical Trial Optimi Health Completes First Export of Psilocybin to the United Kingdom for Phase 2 Clinical Trial PR Newswire VANCOUVER, BC, June 10, 2026 The shipment of naturally derived psilocybin, comprising...

Optimi Health Secures Ibogaine Supply and Commences Finished Drug Product Development

Optimi Health Secures Ibogaine Supply and Commences Finished Drug Product Development Optimi Health Secures Ibogaine Supply and Commences Finished Drug Product Development PR Newswire VANCOUVER, BC, June 8, 2026 Recent US executive order named ibogaine compounds among the psychedelic therapies...

Optimi Health (NASDAQ: OPTH) (CSE: OPTI) Highlights Australia Psychedelic Therapy Expansion Following TGA Framework Update

This article has been disseminated on behalf of Optimi Health Corp. and may include paid advertising. Optimi Health (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN), a commercial-stage psychedelic pharmaceutical manufacturer, welcomed final recommendations from Australia’s Therapeutic Goods Administration regarding its Authorized Prescriber scheme for psilocybin and MDMA. The updated framework broadens eligible therapy teams, expands treatment settings beyond [&#8230;]

Optimi Health Welcomes Expanded Psychedelic-Assisted Therapy Access Under Updated Authorized Prescriber Framework in Australia

Optimi Health Welcomes Expanded Psychedelic-Assisted Therapy Access Under Updated Authorized Prescriber Framework in Australia Optimi Health Welcomes Expanded Psychedelic-Assisted Therapy Access Under Updated Authorized Prescriber Framework in Australia PR Newswire VANCOUVER, BC, May 29, 2026...

Optimi Health Announces Pricing of Oversubscribed US$15 Million Public Offering and Nasdaq Uplisting

Optimi Health Announces Pricing of Oversubscribed US$15 Million Public Offering and Nasdaq Uplisting Optimi Health Announces Pricing of Oversubscribed US$15 Million Public Offering and Nasdaq Uplisting PR Newswire VANCOUVER, BC, May 20, 2026 Common Shares to Trade on the Nasdaq Capital Market Under...

Optimi Health Corp. functions as an end-to-end GMP manufacturer and supplier of psychedelic substances. It offers formulation, active pharmaceutical ingredients (APIs), and drug product manufacturing from preclinical stages to analysis and commercial distribution and It also offers botanical psilocybin and MDMA. The company was founded on May 27, 2020 and is headquartered in Squamish, Canada.

Optimi Health Corp

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$4.85
Prev Close	$4.69
Open	$4.56
Dividend Yield	0.00%
50-Day Moving Average	$4.87
Beta	0.08
Avg. Volume	187,572.39
PE Ratio	-5.20

52-Week High	$8.84
52-Week Low	$3.12
Market Capitalization	$27.29M
EPS (Annual)	-$0.8297
Price to Book	6.17
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info